As of December 2024 ACADIA Pharmaceuticals has a market cap of S$3.79 Billion. This makes ACADIA Pharmaceuticals the world's 3670th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2024 | S$3.79 B | -44.04% |
2023 | S$6.78 B | 96.44% |
2022 | S$3.45 B | -31.87% |
2021 | S$5.07 B | -54.89% |
2020 | S$11.24 B | 25.55% |
2019 | S$8.95 B | 181.81% |
2018 | S$3.17 B | -36.47% |
2017 | S$5.00 B | -1.05% |
2016 | S$5.05 B | -1.66% |
2015 | S$5.14 B | 22.47% |
2014 | S$4.19 B | 45.51% |
2013 | S$2.88 B | 591.7% |
2012 | S$0.41 B | 464.68% |
2011 | S$73.85 M | 21.41% |
2010 | S$60.82 M | -14.37% |
2009 | S$71.03 M | 48.45% |
2008 | S$47.85 M | -91.89% |
2007 | S$0.58 B | 46.19% |
2006 | S$0.40 B | 46.07% |
2005 | S$0.27 B | 48.49% |
2004 | S$0.18 B |
On Dec 18th, 2024 the market cap of ACADIA Pharmaceuticals was reported to be: